Trillium Therapeutics Inc.

Organization

Toronto, CA

Ticker Symbols

NASDAQ:TRIL

PHARMACEUTICAL PREPARATIONS
Business Address
2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Mailing Address
2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
State Location
A6
State of Incorporation
A6

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Treatment of CD47+ disease cells with SIRPα-Fc fusions
- Patent number 10,906,954
- Issue date Feb 2, 2021
- Trillium Therapeutics Inc.
- Robert Adam Uger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of br...
- Patent number 10,696,670
- Issue date Jun 30, 2020
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fluorinated amide derivatives and their uses as therapeutic agents
- Patent number 10,604,476
- Issue date Mar 31, 2020
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of br...
- Patent number 10,259,809
- Issue date Apr 16, 2019
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of CD47+ disease cells with SIRP alpha-Fc fusions
- Patent number 9,969,789
- Issue date May 15, 2018
- Trillium Therapeutics Inc.
- Robert Adam Uger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fluorinated epoxyketone-based compounds and uses thereof as proteas...
- Patent number 9,441,012
- Issue date Sep 13, 2016
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multimeric Fc receptor polypeptides
- Patent number 8,729,247
- Issue date May 20, 2014
- Trillium Therapeutics, Inc.
- Phillip Mark Hogarth
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Assay for soluble CD200
- Patent number 8,206,897
- Issue date Jun 26, 2012
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- G01 - MEASURING TESTING
Information Patent Grant
Methods of treating cancer by administering antibodies to CD200
- Patent number 8,187,598
- Issue date May 29, 2012
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fc receptor modulating compounds and compositions
- Patent number 7,910,770
- Issue date Mar 22, 2011
- Trillium Therapeutics Inc.
- Mark Phillip Hogarth
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for modulating immunity
- Patent number 7,902,151
- Issue date Mar 8, 2011
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating cancer by administering antibodies to CD200
- Patent number 7,887,798
- Issue date Feb 15, 2011
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for modulating immunity
- Patent number 7,553,811
- Issue date Jun 30, 2009
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating cancer by administering antibodies to CD200
- Patent number 7,452,536
- Issue date Nov 18, 2008
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD200 receptors
- Patent number 7,368,535
- Issue date May 6, 2008
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FcγRIIa transgenic animal model for autoimmune disease
- Patent number 7,351,875
- Issue date Apr 1, 2008
- Trillium Therapeutics, Inc.
- Phillip Mark Hogarth
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fc receptor modulating compounds and compositions
- Patent number 7,332,631
- Issue date Feb 19, 2008
- Trillium Therapeutics Inc.
- Mark Phillip Hogarth
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MD-1 inhibitors as immune suppressants
- Patent number 7,291,330
- Issue date Nov 6, 2007
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for modulating tumor growth
- Patent number 7,238,352
- Issue date Jul 3, 2007
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating allergy by administering a CD200 protein
- Patent number 7,223,729
- Issue date May 29, 2007
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Truncated CD200
- Patent number 7,205,386
- Issue date Apr 17, 2007
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transgenic animal containing CD200 and uses therefor
- Patent number 7,196,243
- Issue date Mar 27, 2007
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for modulating autoimmunity
- Patent number 6,984,625
- Issue date Jan 10, 2006
- Trillium Therapeutics Inc.
- Reginald Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inhibiting immune response suppression by administering...
- Patent number 6,955,811
- Issue date Oct 18, 2005
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of modulating immune coagulation
- Patent number 6,805,863
- Issue date Oct 19, 2004
- Trillium Therapeutics Inc.
- Gary Levy
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of OX-2 to inhibit fetal loss
- Patent number 6,749,854
- Issue date Jun 15, 2004
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of OX-2 to suppress an immune response
- Patent number 6,652,858
- Issue date Nov 25, 2003
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fgl-2 knockout mice
- Patent number 6,642,433
- Issue date Nov 4, 2003
- Trillium Therapeutics Inc.
- Gary Levy
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
BIOMARKERS FOR CD47 BLOCKADE THERAPY
- Publication number 20220289821
- Publication date Sep 15, 2022
- Trillium Therapeutics Inc.
- Lisa Danae Schultz Johnson
- G01 - MEASURING TESTING
Information Patent Application
CD47 BLOCKADE WITH PARP INHIBITION FOR DISEASE TREATMENT
- Publication number 20210315864
- Publication date Oct 14, 2021
- Trillium Therapeutics Inc.
- Lisa Danae Schultz Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CD47+ DISEASE CELLS WITH SIRP ALPHA-FC FUSIONS
- Publication number 20210206829
- Publication date Jul 8, 2021
- Trillium Therapeutics Inc.
- Robert Adam Uger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD47 BLOCKADE THERAPY WITH CD38 ANTIBODY
- Publication number 20210040224
- Publication date Feb 11, 2021
- Trillium Therapeutics Inc.
- Gloria Hoi Ying LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMPROVEMENTS IN CD47 BLOCKADE THERAPY BY EGFR ANTIBODY
- Publication number 20210040219
- Publication date Feb 11, 2021
- Trillium Therapeutics Inc.
- Gloria Hoi Ying LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS
- Publication number 20200181067
- Publication date Jun 11, 2020
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD47 BLOCKADE THERAPY
- Publication number 20200157179
- Publication date May 21, 2020
- Trillium Therapeutics Inc.
- Gloria Hoi Ying LIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC-FUSED IMIDAZOLYL AMIDES, COMPOSITIONS AND USES THERE...
- Publication number 20200031825
- Publication date Jan 30, 2020
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISO...
- Publication number 20190367466
- Publication date Dec 5, 2019
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMPROVEMENTS IN CD47 BLOCKADE THERAPY BY HDAC INHIBITORS
- Publication number 20190269756
- Publication date Sep 5, 2019
- Trillium Therapeutics Inc.
- Emma Linderoth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS
- Publication number 20190255082
- Publication date Aug 22, 2019
- Trillium Therapeutics Inc.
- Emma Linderoth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BR...
- Publication number 20190202825
- Publication date Jul 4, 2019
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROPHAGE STIMULATION IN CD47 BLOCKADE THERAPY
- Publication number 20190091290
- Publication date Mar 28, 2019
- Trillium Therapeutics Inc.
- Gloria Hoi Ying Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL FLUORINATED QUINAZOLINE DERIVATIVES AS EGFR INHIBITORS
- Publication number 20190016689
- Publication date Jan 17, 2019
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS
- Publication number 20180334425
- Publication date Nov 22, 2018
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISO...
- Publication number 20180312480
- Publication date Nov 1, 2018
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions
- Publication number 20180312563
- Publication date Nov 1, 2018
- Trillium Therapeutics Inc.
- Robert Adam Uger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL FLUORINATED DERIVATIVES AS EGFR INHIBITORS USEFUL FOR TREATIN...
- Publication number 20180050993
- Publication date Feb 22, 2018
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BR...
- Publication number 20180016271
- Publication date Jan 18, 2018
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR THE SYNTHESIS OF DIFLUOROMETHYL ETHER-BASED COMPOUNDS
- Publication number 20180016227
- Publication date Jan 18, 2018
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FLUORINATED EPOXYKETONE-BASED COMPOUNDS AND USES THEREOF AS PROTEAS...
- Publication number 20160347792
- Publication date Dec 1, 2016
- Trillium Therapeutics Inc.
- Abdelmalik Slassi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions
- Publication number 20150329616
- Publication date Nov 19, 2015
- TRILLIUM THERAPEUTICS INC.
- Robert Adam Uger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HB-EGF Composition and Use Thereof to Treat a Condition Associated...
- Publication number 20130102532
- Publication date Apr 25, 2013
- TRILLIUM THERAPEUTICS INC.
- Robert Uger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Assay for Soluble CD200
- Publication number 20120264145
- Publication date Oct 18, 2012
- Trillium Therapeutics Inc.
- Reginald M. Gorczynski
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND COMPOSITIONS FOR MODULATING IMMUNITY
- Publication number 20110206668
- Publication date Aug 25, 2011
- TRILLIUM THERAPEUTICS INC.
- REGINALD M. GORCZYNSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCER BY ADMINISTERING ANTIBODIES TO CD200
- Publication number 20110129466
- Publication date Jun 2, 2011
- Trillium Therapeutics Inc.
- REGINALD M. GORCZYNSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Compositions For Modulating Immunity
- Publication number 20090232825
- Publication date Sep 17, 2009
- TRILLIUM THERAPEUTICS INC.
- REGINALD M. GORCZYNSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Cancer by Administering Antibodies to CD200
- Publication number 20090053222
- Publication date Feb 26, 2009
- Trillium Therapeutics Inc.
- REGINALD M. GORCZYNSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc Receptor Modulating Compounds and Compositions
- Publication number 20080146632
- Publication date Jun 19, 2008
- TRILLIUM THERAPEUTICS, INC.
- Mark Phillip Hogarth
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Multimeric Fc Receptor Polypeptides
- Publication number 20080008700
- Publication date Jan 10, 2008
- TRILLIUM THERAPEUTICS, INC.
- Phillip Mark Hogarth
- C07 - ORGANIC CHEMISTRY

Trillium Therapeutics Inc.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Treatment of CD47+ disease cells with SIRPα-Fc fusions

Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of br...

Fluorinated amide derivatives and their uses as therapeutic agents

Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of br...

Treatment of CD47+ disease cells with SIRP alpha-Fc fusions

Fluorinated epoxyketone-based compounds and uses thereof as proteas...

Multimeric Fc receptor polypeptides

Assay for soluble CD200

Methods of treating cancer by administering antibodies to CD200

Fc receptor modulating compounds and compositions

Methods and compositions for modulating immunity

Methods of treating cancer by administering antibodies to CD200

Methods and compositions for modulating immunity

Methods of treating cancer by administering antibodies to CD200

CD200 receptors

FcγRIIa transgenic animal model for autoimmune disease

Fc receptor modulating compounds and compositions

MD-1 inhibitors as immune suppressants

Methods and compositions for modulating tumor growth

Methods of treating allergy by administering a CD200 protein

Truncated CD200

Transgenic animal containing CD200 and uses therefor

Methods and compositions for modulating autoimmunity

Methods of inhibiting immune response suppression by administering...

Methods of modulating immune coagulation

Use of OX-2 to inhibit fetal loss

Use of OX-2 to suppress an immune response

Fgl-2 knockout mice

Patents Applicationslast 30 patents

BIOMARKERS FOR CD47 BLOCKADE THERAPY

CD47 BLOCKADE WITH PARP INHIBITION FOR DISEASE TREATMENT

TREATMENT OF CD47+ DISEASE CELLS WITH SIRP ALPHA-FC FUSIONS

CD47 BLOCKADE THERAPY WITH CD38 ANTIBODY

IMPROVEMENTS IN CD47 BLOCKADE THERAPY BY EGFR ANTIBODY

FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS

CD47 BLOCKADE THERAPY

HETEROAROMATIC-FUSED IMIDAZOLYL AMIDES, COMPOSITIONS AND USES THERE...

HETEROCYCLE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISO...

IMPROVEMENTS IN CD47 BLOCKADE THERAPY BY HDAC INHIBITORS

ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS

FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BR...

MACROPHAGE STIMULATION IN CD47 BLOCKADE THERAPY

NOVEL FLUORINATED QUINAZOLINE DERIVATIVES AS EGFR INHIBITORS

FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS

HETEROCYCLE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISO...

Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions

NOVEL FLUORINATED DERIVATIVES AS EGFR INHIBITORS USEFUL FOR TREATIN...

FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BR...

PROCESS FOR THE SYNTHESIS OF DIFLUOROMETHYL ETHER-BASED COMPOUNDS

FLUORINATED EPOXYKETONE-BASED COMPOUNDS AND USES THEREOF AS PROTEAS...

Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions

HB-EGF Composition and Use Thereof to Treat a Condition Associated...

Assay for Soluble CD200

METHODS AND COMPOSITIONS FOR MODULATING IMMUNITY

METHODS OF TREATING CANCER BY ADMINISTERING ANTIBODIES TO CD200

Methods and Compositions For Modulating Immunity

Methods of Treating Cancer by Administering Antibodies to CD200

Fc Receptor Modulating Compounds and Compositions

Multimeric Fc Receptor Polypeptides

Trademarklast 30 trademarks